Reports >
Life Sciences
>
Genetic Testing Market Report
Genetic Testing Market Report
First published: 21 October 2024 | Last updated: 25 May 2026 | Report Code: genetic-testing
Genetic Testing Market — USD 10.5 billion in 2023, Growing to USD 26.34B by 2033 at 9.3% CAGR
This report provides a comprehensive analysis of the Genetic Testing market, including detailed insights on market size, growth trends, segmentation, technological advancements, and regional developments from 2023 to 2033.
Key Takeaways
- Global market value grows from $10.50 Billion in 2023 to $26.34 Billion by 2033 at a 9.3% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe increases from $2.59 Billion to $6.51 Billion and Asia Pacific from $2.01 Billion to $5.04 Billion over the forecast.
- Segmentation covers methods, products, end users, technologies, and applications with multiple subsegments listed.
- Leading companies include Illumina, Inc., Abbott Laboratories, Myriad Genetics, Roche Diagnostics, and Thermo Fisher Scientific.
Genetic Testing Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report provides a structured analysis of the genetic testing sector, reporting a market size of $10.50 Billion in 2023 and a projected $26.34 Billion by 2033 at a 9.3% CAGR for 2023 to 2033. Growth is driven by rising demand for diagnostic and predictive testing, broader adoption of sequencing technologies, and integration of genetics into personalized medicine and preventive healthcare. The study assesses market segmentation across methods, products, end users, technologies, and applications, and examines regional trajectories including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive profiling highlights major participants such as Illumina, Inc., Abbott Laboratories, Myriad Genetics, Roche Diagnostics, and Thermo Fisher Scientific. The report also addresses regulatory considerations, privacy concerns, and the role of partnerships between healthcare providers, laboratories, and technology firms in advancing market offerings.
Key Growth Drivers
- Increasing incorporation of genetic testing into personalized and preventive healthcare expanding clinical use cases.
- Advancements in sequencing and genotyping technologies lowering per-test costs and enhancing diagnostic precision.
- Rising awareness of genetic disorders and greater healthcare spending supporting broader market adoption.
- Collaboration among healthcare providers, labs, and technology companies accelerating product development and market access.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $10.50 Billion |
| CAGR (2023-2033) | 9.3% |
| 2033 Market Size | $26.34 Billion |
| Top Companies | Illumina, Inc., Abbott Laboratories, Myriad Genetics, Roche Diagnostics, Thermo Fisher Scientific |
| Published Date | 21 October 2024 |
| Last Modified Date | 25 May 2026 |
Genetic Testing Market Overview
Customize Genetic Testing Market Report market research report
- ✔ Get in-depth analysis of Genetic Testing market size, growth, and forecasts.
- ✔ Understand Genetic Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Genetic Testing
What is the Market Size & CAGR of Genetic Testing Market Report market in 2023?
Genetic Testing Industry Analysis
Genetic Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Genetic Testing Market Report Market Analysis Report by Region
Europe Genetic Testing Market Report:
Europe grows from $2.59 Billion in 2023 to $6.51 Billion in 2033. Regional expansion is supported by rising incorporation of genetic testing in clinical workflows, regulatory evolution, and investments in research and diagnostic capabilities.Asia Pacific Genetic Testing Market Report:
Asia Pacific grows from $2.01 Billion in 2023 to $5.04 Billion in 2033. Market momentum is driven by increasing healthcare spending, growing awareness of genetic conditions, and expanding laboratory networks and technology uptake.North America Genetic Testing Market Report:
North America is largest regional market, rising from $4 Billion in 2023 to $10.04 Billion in 2033. Growth reflects strong clinical adoption, advanced laboratory infrastructure, high healthcare investment, and active participation by major firms in sequencing and diagnostics.South America Genetic Testing Market Report:
Latin America grows from $0.91 Billion in 2023 to $2.28 Billion in 2033. Growth is underpinned by rising demand for diagnostic and predictive tests, gradual expansion of healthcare services, and improving access to testing technologies.Middle East & Africa Genetic Testing Market Report:
Middle East and Africa grows from $0.98 Billion in 2023 to $2.47 Billion in 2033. Drivers include growing healthcare investment, expanding diagnostic services, and increasing attention to genetics in clinical and research settings.Tell us your focus area and get a customized research report.
Research Methodology
Genetic Testing Market Analysis By Product
The Molecular Testing segment is the largest, valued at $6.40 billion in 2023 and expected to reach $16.06 billion by 2033, accounting for 60.98% of the market. Cytogenetic Testing holds a market share of 26.16%, with an expected growth from $2.75 billion in 2023 to $6.89 billion by 2033. Biochemical Testing is expected to grow from $1.35 billion to $3.39 billion, maintaining a 12.86% market share.
Genetic Testing Market Analysis By Application
The market segments by application include Diagnostics, Predictive Tests, and Pharmacogenomic Tests. Diagnostic tests dominate the market with 60.98% share, projected to grow from $6.40 billion to $16.06 billion. Predictive and Pharmacogenomic tests have shares of 26.16% and 12.86%, expected to grow significantly by 2033.
Genetic Testing Market Analysis By End User
Hospitals are the leading end-user segment, projected to expand from $6.16 billion in 2023 to $15.44 billion by 2033, with a market share of 58.63%. Laboratories and pharmaceutical companies will also see growth, with laboratory testing set to grow from $2.13 billion to $5.35 billion.
Genetic Testing Market Analysis By Method
Key methods include Next Generation Sequencing, SNP Genotyping, and Whole Exome Sequencing. NGS leads with $6.40 billion in 2023, expected to reach $16.06 billion by 2033. SNP Genotyping and Whole Exome Sequencing exhibit significant growth rates as well, enhancing the overall testing capabilities.
Genetic Testing Market Analysis By Technology
The market utilizes various technologies, with advancements paving the way for more efficient testing methods. Innovations in digital tools and bioinformatics are revolutionizing genetic testing, enhancing accuracy, and reducing costs, leading to wider adoption.
Genetic Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Genetic Testing Industry
Illumina, Inc.:
Illumina leads the market with its advanced sequencing technology and has a significant presence in clinical diagnostics and personalized medicine.Abbott Laboratories:
A global leader in diagnostics, Abbott offers a wide range of genetic testing solutions, focusing on improving patient outcomes.Myriad Genetics:
Specializing in hereditary cancer testing, Myriad has pioneered genetic testing services that help patients make informed healthcare decisions.Roche Diagnostics:
With a strong portfolio in molecular diagnostics, Roche is committed to developing innovative genetic testing solutions for various applications.Thermo Fisher Scientific:
Known for its comprehensive range of genetic testing technologies, Thermo Fisher enables advancements in genomic research and clinical applications.We're grateful to work with incredible clients.
FAQs
What is the current market size of the genetic testing market?
The market size for 2023 is $10.50 Billion according to the report's stated figures and scope.
How big will the genetic testing market be in 2033?
The market is projected to reach $26.34 Billion by 2033 as provided in the report data.
What is the CAGR for the forecast period?
The stated compound annual growth rate for 2023 to 2033 is 9.3% in the report.
Which region is the largest market for genetic testing?
North America is identified as the largest regional market, growing from $4 Billion in 2023 to $10.04 Billion in 2033.
Why is North America the largest regional market?
The region's scale reflects established clinical adoption, advanced lab infrastructure, and investment in sequencing and diagnostics.
Who are the leading companies in this market?
Top companies listed include Illumina, Inc., Abbott Laboratories, Myriad Genetics, Roche Diagnostics, and Thermo Fisher Scientific.
Which segments are covered in the report?
Segment coverage includes methods, products, end users, technologies, and applications with listed subsegments for each category.
How big is the market in Europe in 2023 and 2033?
Europe's market size is $2.59 Billion in 2023 and grows to $6.51 Billion by 2033 as stated.
How big is the market in Asia Pacific in 2023 and 2033?
Asia Pacific is reported at $2.01 Billion in 2023 and $5.04 Billion in 2033.
Is there a single fastest Growing region in the Genetic Testing Market Report market?
No single fastest-growing region is stated for the Genetic Testing Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.